Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sucralfate suspensoid gel after esophageal ESD for artificial ulcer healing
ChiCTR1900026441Phase 4Not yet recruiting
- Sponsor
- Shanghai Changzheng Hospital
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sucralfate in Esophageal ulcer (2 arms), sponsored by Shanghai Changzheng Hospital. Primary endpoint: Ulcer healing rate. Planned start Nov 2019; status: not yet recruiting.
02
Drugs
sucralfate
03
Conditions
Esophageal ulcer
Beyond the preview
Go deeper on ChiCTR1900026441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026441.